On Friday, Shares of Zoetis Inc (NYSE:ZTS), subtract -1.65% and closed at $50.18 in the last trading session. The last trading range of the stock ranges between $50.18 and $51.17. Zoetis Inc. (ZTS) will take part in the 25th Annual Credit Suisse Healthcare Conference on Tuesday, Nov. 8, 2016, in Scottsdale, Ariz. Kristin Peck, Executive Vice President and President, U.S. Operations, will represent the company and respond to questions from analysts. She is planned to present at 3:00 p.m. EST (1:00 p.m. MST).
Raptor Pharmaceutical Corp. (NASDAQ:RPTP), remained flat and closed at $8.98 in the last trading session. The last trading range of the stock ranges between $8.98 and $9.00. The company’s Market capitalization is $766.05 million with the total outstanding Shares of 85.31 million. Gainey McKenna & Egleston declares that a class action lawsuit has been filed against Raptor Pharmaceutical Corp. (“Raptor” or the “Company”) (RPTP) in the United States District Court for the District of Delaware on behalf of current stockholders of Raptor, seeking to pursue remedies under the Securities Exchange Act of 1934 (the “Exchange Act”).
The Complaint alleges that on September 12, 2016, Raptor and Horizon Pharma Public Limited Company (“Horizon”) declared a definitive agreement and plan of merger following which Horizon will acquire each outstanding common share of Raptor for $9 per share in cash (the “Merger”). While the 50-day ($6.52) and 200-day ($5.19) moving averages for Raptor stock were below the $9/share transaction price before the Merger’s declarement, a closer look reveals that formerly, shares of Raptor had consistently traded at or above the $9/share mark since 2013.
The Complaint alleges that the projected Merger fails to reflect Raptor’s true value. Analyst expectations, historical trading prices, Raptor’s recent results, and an exciting pipeline of products that are either in the market already and/or coming soon to market demonstrate that the Merger undervalues the Company. Significantly, as recently as April 12, 2016, Leerink Swann reaffirmed its Outperform rating on Raptor shares while setting an $11/share price target for Company stock. Further to this, the Company has grown global net revenue for PROCYSBI in no fewer than ten successive quarters, and the terrific launch of QUINSAIR in Europe during the last quarter – the first time that revenue from QUINSAIR has augmented revenue from PROCYSBI – has caused Raptor to revise upward its financial guidance for the remainder of 2016.
Murphy Oil Corporation (NYSE:MUR), gained 1.12% and closed at $28.98 in the last trading session. The last trading range of the stock ranges between $29.40 and $28.56. The company’s Market capitalization is $5.05 Billion with the total outstanding Shares of 172.20 million. During the 52-week trading session the minimum price at which share price traded, registered at $14.30 and reached to max level of $37.48. Murphy Oil Corporation (MUR) has planned its third quarter 2016 earnings webcast and conference call at 1:00 p.m. Eastern Time (ET), on Thursday, October 27, 2016. Third quarter 2016 earnings will be declared after market close on Wednesday, October 26, 2016 and will be available on the company`s website.